Investigation of Hepatitis B and Hepatitis C in Taiwan

This study has been completed.
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00946010
First received: April 1, 2008
Last updated: January 20, 2011
Last verified: January 2011
  Purpose

The purpose of this study is to investigate the differences of genotypes of hepatitis B and hepatitis C in Taiwan.


Condition Intervention
Hepatitis B
Hepatitis C
Biological: blood sampling and abdominal sonography

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Investigation of Hepatitis B and Hepatitis C in Taiwan

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:
  • genotype and DNA level or RNA level of HBV and HCV virus [ Time Frame: once during Mar. 2008- Jan. 2011 ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

10ml blood was sampled and then serum was be retained.


Enrollment: 6228
Study Start Date: April 2008
Study Completion Date: January 2011
Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Click here for more information about this study: Investigation of Hepatitis B and Hepatitis C in Taiwan
Biological: blood sampling and abdominal sonography
10cc blood sampling and abdominal sonography
Other Name: 10cc blood sampling and abdominal sonography

Detailed Description:

The purpose of this study is investigating the differences of genotypes and DNA level or RNA level of hepatitis B and hepatitis C in Taiwan.

  Eligibility

Ages Eligible for Study:   23 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

People Born before 1985/01/01 who live in Taiwan are HBV or HCV pateints.

Criteria

Inclusion Criteria:

  • Born before 1985/01/01
  • HBV or HCV carriers

Exclusion Criteria:

  • N/A
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00946010

Locations
Taiwan
National Taiwan University Hospital
Taipei, Taiwan, 100
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Study Chair: Jin-Chuan Sheu, M.D. P.H.D. National Taiwan University Hospital
  More Information

No publications provided

Responsible Party: National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT00946010     History of Changes
Other Study ID Numbers: 200801059R
Study First Received: April 1, 2008
Last Updated: January 20, 2011
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
Hepatitis B
Hepatitis C
genotype
DNA level
RNA level
Taiwan

Additional relevant MeSH terms:
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis, Viral, Human
Liver Diseases
Digestive System Diseases
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Hepadnaviridae Infections
DNA Virus Infections
Flaviviridae Infections

ClinicalTrials.gov processed this record on April 17, 2014